Increases in Xu Zheng and Yu Zheng among patients with breast cancer receiving different anticancer drug therapies

Chen Jei Tai, Sheng Miauh Huang, Li Yin Chien, Cheng Jeng Tai, Ling Ming Tseng, Ping Ho Chen

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim. The objectives of this study were to compare yang-xu, yin-xu, and yu among patients with breast cancer right before, one month after, and three months after receiving target, chemo, or combined therapy. Method. After recruiting 126 patients from 4 hospitals in northern Taiwan, a longitudinal study was carried out with 61 patients receiving chemotherapy, 30 receiving target therapy, and 35 receiving combined therapy. Yang-xu, yin-xu, and yu were assessed using the Traditional Chinese Medical Constitutional Scale (TCMCS), with higher scores indicating more xu and yu. Results. There were significant increases in yang-xu, yin-xu, and yu at 1 month and 3 months after than before the start of the chemotherapy, target, or combined therapy. Patients receiving combined therapy had significantly higher scores in yang-xu and yin-xu than patients receiving chemo or target therapy. A history of coronary heart disease was associated with more yin-xu. Those patients who had undergone a mastectomy were associated with less yu zheng than those patients who had not. Conclusion and Implications. TCM doctors should focus their treatment on dealing with xu and yu in order to support their patients, as they complete their modern anticancer treatments.

Original languageEnglish
Article number392024
JournalEvidence-based Complementary and Alternative Medicine
Volume2013
DOIs
Publication statusPublished - 2013

Fingerprint

Yin Deficiency
Yang Deficiency
Breast Neoplasms
Drug Therapy
Therapeutics
Mastectomy
Taiwan
Coronary Disease
Longitudinal Studies

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Increases in Xu Zheng and Yu Zheng among patients with breast cancer receiving different anticancer drug therapies. / Tai, Chen Jei; Huang, Sheng Miauh; Chien, Li Yin; Tai, Cheng Jeng; Tseng, Ling Ming; Chen, Ping Ho.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2013, 392024, 2013.

Research output: Contribution to journalArticle

@article{f19121c143f3432882e0f3aac6063dcd,
title = "Increases in Xu Zheng and Yu Zheng among patients with breast cancer receiving different anticancer drug therapies",
abstract = "Aim. The objectives of this study were to compare yang-xu, yin-xu, and yu among patients with breast cancer right before, one month after, and three months after receiving target, chemo, or combined therapy. Method. After recruiting 126 patients from 4 hospitals in northern Taiwan, a longitudinal study was carried out with 61 patients receiving chemotherapy, 30 receiving target therapy, and 35 receiving combined therapy. Yang-xu, yin-xu, and yu were assessed using the Traditional Chinese Medical Constitutional Scale (TCMCS), with higher scores indicating more xu and yu. Results. There were significant increases in yang-xu, yin-xu, and yu at 1 month and 3 months after than before the start of the chemotherapy, target, or combined therapy. Patients receiving combined therapy had significantly higher scores in yang-xu and yin-xu than patients receiving chemo or target therapy. A history of coronary heart disease was associated with more yin-xu. Those patients who had undergone a mastectomy were associated with less yu zheng than those patients who had not. Conclusion and Implications. TCM doctors should focus their treatment on dealing with xu and yu in order to support their patients, as they complete their modern anticancer treatments.",
author = "Tai, {Chen Jei} and Huang, {Sheng Miauh} and Chien, {Li Yin} and Tai, {Cheng Jeng} and Tseng, {Ling Ming} and Chen, {Ping Ho}",
year = "2013",
doi = "10.1155/2013/392024",
language = "English",
volume = "2013",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Increases in Xu Zheng and Yu Zheng among patients with breast cancer receiving different anticancer drug therapies

AU - Tai, Chen Jei

AU - Huang, Sheng Miauh

AU - Chien, Li Yin

AU - Tai, Cheng Jeng

AU - Tseng, Ling Ming

AU - Chen, Ping Ho

PY - 2013

Y1 - 2013

N2 - Aim. The objectives of this study were to compare yang-xu, yin-xu, and yu among patients with breast cancer right before, one month after, and three months after receiving target, chemo, or combined therapy. Method. After recruiting 126 patients from 4 hospitals in northern Taiwan, a longitudinal study was carried out with 61 patients receiving chemotherapy, 30 receiving target therapy, and 35 receiving combined therapy. Yang-xu, yin-xu, and yu were assessed using the Traditional Chinese Medical Constitutional Scale (TCMCS), with higher scores indicating more xu and yu. Results. There were significant increases in yang-xu, yin-xu, and yu at 1 month and 3 months after than before the start of the chemotherapy, target, or combined therapy. Patients receiving combined therapy had significantly higher scores in yang-xu and yin-xu than patients receiving chemo or target therapy. A history of coronary heart disease was associated with more yin-xu. Those patients who had undergone a mastectomy were associated with less yu zheng than those patients who had not. Conclusion and Implications. TCM doctors should focus their treatment on dealing with xu and yu in order to support their patients, as they complete their modern anticancer treatments.

AB - Aim. The objectives of this study were to compare yang-xu, yin-xu, and yu among patients with breast cancer right before, one month after, and three months after receiving target, chemo, or combined therapy. Method. After recruiting 126 patients from 4 hospitals in northern Taiwan, a longitudinal study was carried out with 61 patients receiving chemotherapy, 30 receiving target therapy, and 35 receiving combined therapy. Yang-xu, yin-xu, and yu were assessed using the Traditional Chinese Medical Constitutional Scale (TCMCS), with higher scores indicating more xu and yu. Results. There were significant increases in yang-xu, yin-xu, and yu at 1 month and 3 months after than before the start of the chemotherapy, target, or combined therapy. Patients receiving combined therapy had significantly higher scores in yang-xu and yin-xu than patients receiving chemo or target therapy. A history of coronary heart disease was associated with more yin-xu. Those patients who had undergone a mastectomy were associated with less yu zheng than those patients who had not. Conclusion and Implications. TCM doctors should focus their treatment on dealing with xu and yu in order to support their patients, as they complete their modern anticancer treatments.

UR - http://www.scopus.com/inward/record.url?scp=84876532057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876532057&partnerID=8YFLogxK

U2 - 10.1155/2013/392024

DO - 10.1155/2013/392024

M3 - Article

VL - 2013

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 392024

ER -